MoneyWorks4Me

Span Diagnostics strengthens on disinvesting its entire stake in Span Nihon Kohden Diagnostics

20 Nov 2015 Evaluate

Span Diagnostics is currently trading at Rs. 61.40, up by 2.70 points or 4.60% from its previous closing of Rs. 58.70 on the BSE.

The scrip opened at Rs. 58.00 and has touched a high and low of Rs. 64.85 and Rs. 58.00 respectively. So far 1521 shares were traded on the counter.

The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.00 on 21-Oct-2015 and a 52 week low of Rs. 42.55 on 09-Feb-2015.

Last one week high and low of the scrip stood at Rs. 64.85 and Rs. 56.05 respectively. The current market cap of the company is Rs. 42.71 crore.

The promoters holding in the company stood at 44.18% while Non-Institutions held 55.82% stake in the company. 

Span Diagnostics has disinvested its entire 45% stake held in Joint Venture Company (JVC) namely Span Nihon Kohden Diagnostics. The company has disinvested the same to Nihon Khoden Corporation, Japan for consideration of Rs 8.02 crore.

Span Diagnostics caters to several different sections of diagnostics like Immunology, Biochemistry, Microbiology, Serology, Histopathology and instrumentation. The company’s manufacturing capabilities comprise of advanced infrastructure, highly trained and motivated pool of scientific and technical personnel and years of experience.

 

Peers
Company Name CMP
Godrej Industries 1102.90
SRF 2467.00
BASF India 3576.60
Pidilite Inds. 1543.50
Tata Chemicals 734.50
View more..